InsiderClue
Stocks · Health care · Pharmaceutical Preparations

RHYTHM PHARMACEUTICALS, INC.

RYTM Clue Score45
United States Fiscal year ends December CIK 0001649904 Results filed 3 Nov 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

9
Insider
Date
Role
Action
Shares
Price
Amount
Hunter C Smith
18 May 2026
Chief Financial Officer
Exercised, kept
3,000
$17.87
$53.61K
Hunter C Smith
2 Mar 2026
Chief Financial Officer
Exercised, kept
6,099
$6.80
$41.47K
Hunter C Smith
7 Jul 2025
Chief Financial Officer
Exercised, kept
6,986
$6.88
$48.06K
Jennifer Kayden Lee
9 Feb 2025
EVP, Head of North America
Exercised, kept
4,189
$6.80
$28.49K
Hunter C Smith
29 Dec 2023
Chief Financial Officer
Exercised, kept
10,500
$6.88
$72.24K
Hunter C Smith
16 Jun 2023
Chief Financial Officer
Exercised, kept
2,000
$6.88
$13.76K
Hunter C Smith
21 Apr 2021
Chief Financial Officer
Exercised, kept
5,000
$6.88
$34.40K
Hunter C Smith
19 Jan 2021
Chief Financial Officer
Exercised, kept
4,000
$6.88
$27.52K
Nithya Desikan
11 Aug 2020
Chief Commercial Officer
Exercised, kept
14,534
$6.88
$99.99K
Showing 250 of 351 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 376
Amendments (4/A) skipped 8
Filings about a different issuer 0
Unreadable filings 0
Joint filings 12
Sales on a Rule 10b5-1 plan 58
Sales straight out of an exercise 139
Sales at will 113
Transactions with no price 0
Shares from compensation/vesting 53,596,983
Sales filed before the plan box existed 89
History held since 6 Oct 2017